References
-
1
Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T.
Middle MA randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
J Clin Psychopharmacol.
2004;
24
62-69
-
2
Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R.
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.
Eur Heart J.
2000;
21
1216-1231
-
3
Haverkamp W, Deuschle M.
Lengthening of QT interval by antipsychotic drugs.
Nervenarzt.
2006;
77
276-288
-
4
Ostrom M, Eriksson A, Thorson J, Spigset O.
Fatal overdose with citalopram.
Lancet.
1996;
348
339-340
-
5
Personne M, Persson H, Sjoberg E.
Citalopram toxicity.
Lancet.
1997;
350
518-519
-
6
Ravina T, Ravina P, Gutierrrez J.
Acquired long QT syndrome: Risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block.
I. Int J Cardiol.
2006;
25
, [Epub ahead of print]
Correspondence
Dr. med. D. Blaschke
Charité- Universitätsmedizin Berlin
Campus Virchow-Klinikum
Medizinische Klinik mit Schwerpunkt Kardiologie
Augustenburger Platz 1
13353 Berlin
Germany
Telefon: +49/30/450 653 366
Fax: +49/30/450 553 957
eMail: daniela.blaschke@charite.de
